Sestrin2 prevents age‐related intolerance to ischemia and reperfusion injury by modulating substrate metabolism. Issue 9 (19th September 2017)

• Record Type: Journal Article
• Authors: Quan, Nanhu; Sun, Wanqing; Wang, Lin; Chen, Xu; Bogan, Jonathan S.; Zhou, Xinchun; Cates, Courtney; Liu, Quan; Zheng, Yang; Li, Ji
• Is Part Of: FASEB journal. Volume 31:Issue 9(2017)
• Page Start: 4153
• Page End: 4167
• Publication Date: 2017-09-19
• Subjects: aging -- AMPK -- glucose transport; Biology -- Periodicals; Biology, Experimental -- Periodicals; 570
• DOI: 10.1096/fj.201700063R
• Languages: English
• ISSNs: 0892-6638

Abstract

ABSTRACT: A novel stress‐inducible protein, Sestrin2 (Sesn2), declines in the heart with aging. AMPK has emerged as a pertinent stress‐activated kinase that has been shown to have cardioprotective capabilities against myocardial ischemic injury. We identified the interaction between Sesn2 and AMPK in the ischemic heart. To determine whether ischemic AMPK activation—modulated by the Sesn2‐AMPK complex in the heart—is impaired in aging that sensitizes the heart to ischemic insults, young C57BL/6 mice (age 3–4 mo), middle‐aged mice (age 10–12 mo), and aged mice (age 24–26 mo) were subjected to left anterior descending coronary artery occlusion for in vivo regional ischemia. The ex vivo working heart system was used for measuring substrate metabolism. The protein level of Sesn2 in hearts was gradually decreased with aging. Of interest, ischemic AMPK activation was blunted in aged hearts compared with young hearts ( P < 0.05); the AMPK downstream glucose uptake and the rate of glucose oxidation were significantly impaired in aged hearts during ischemia and reperfusion ( P < 0.05 vs. young hearts). Myocardial infarction size was larger in aged hearts ( P < 0.05 vs. young hearts). Immunoprecipitation with Sesn2 Ab revealed that cardiac Sesn2 forms a complex with AMPK and upstream liver kinase B1 (LKB1) during ischemia. Of interest, the binding affinity between Sesn2 and AMPK upstream LKB1 is impaired in aged hearts during ischemia ( P < 0.05 vs. young hearts). Furthermore, Sesn2‐knockout hearts demonstrate a cardiac phenotype and response to ischemic stress that is similar to wild‐type aged hearts ( i.e., impaired ischemic AMPK activation and higher sensitivity to ischemia‐ and reperfusion‐ induced injury). Adeno‐associated virus–Sesn2 was delivered to aged hearts via a coronary delivery approach and significantly rescued the protein level of Sesn2 and the ischemic tolerance of aged hearts; therefore, Sesn2 is a scaffold protein that mediates AMPK activation in the ischemic myocardium via an interaction with AMPK upstream LKB1. Decreased Sesn2 levels in aging lead to a blunted ischemic AMPK activation, alterations in substrate metabolism, and an increased sensitivity to ischemic insults—Quan, N., Sun, W., Wang, L., Chen, X., Bogan, J. S., Zhou, X., Cates, C., Liu, Q., Zheng, Y., Li J. Sestrin2 prevents age‐related intolerance to ischemia and reperfusion injury by modulating substrate metabolism. FASEB J. 31, 4153–4167 (2017). www.fasebj.org —Quan, Nanhu, Sun, Wanqing, Wang, Lin, Chen, Xu, Bogan, Jonathan S., Zhou, Xinchun, Cates, Courtney, Liu, Quan, Zheng, Yang, Li, Ji Sestrin2 prevents age‐related intolerance to ischemia and reperfusion injury by modulating substrate metabolism. FASEB J. 31, 4153–4167 (2017)